APP下载

经腹直肠癌根治术中保留左结肠动脉的临床研究

2021-02-03杨利民

婚育与健康 2021年23期

杨利民

【摘 要】目的:探究经腹直肠癌根治术(TME)中保留左结肠动脉研究。方法:选择130例TME手术患者进行研究。将其根据是否保留左结肠动脉来划分组别,并执行对应的手术操作。最后对两组围手术期指标等进行比较。结果:从围手术期相关指标对比,除了在手术用时、出血量上无明显差异,其他指标均是保留组的情况更佳(P<0.05)。其次,保留组初次排气、排便时间更短(P<0.05)。最后,据随访调查可知,保留组局部复发率为1.54%、远处转移率6.15%,恢复率98.46%;非保留组分别为1.54%、3.08%、92.31%(P<0.05)。结论:在TME手术中保留左结肠动脉,能够加快患者吻合口的愈合,提升恢复率,当然也对其胃肠功能改善起到积极作用。

【关键词】直肠癌;TME;左结肠动脉;胃肠道功能

Clinical study of preservation of the left colic artery during transabdominal resection for rectal cancer

Yang limin

Qianxi People’s Hospital, Tangshan Hebei 064300, China

【Abstract】Objective:To study the preservation of left colonic artery in transabdominal radical resection (TME) for rectal cancer. Methods: 130 patients with TME were studied. They were divided into groups according to whether to retain the left colonic artery, and the corresponding surgical operations were performed. Finally, the perioperative indexes of the two groups were compared. Results: from the comparison of perioperative related indexes, except that there was no significant difference in operation time and bleeding volume, the other indexes were better in the retention group(P<0.05).Secondly, the initial exhaust and defecation time in the retention group was shorter(P<0.05). Finally, according to the follow-up survey, the local recurrence rate, distant metastasis rate and recovery rate in the retention group were 1.54%, 6.15% and 98.46%; The non retention group was 1.54%, 3.08% and 92.31%, respectively(P<0.05).Conclusion: preserving the left colonic artery in TME can accelerate the healing of anastomotic stoma and improve the recovery rate. Of course, it also plays a positive role in the improvement of gastrointestinal function.

【Key?Words】Rectal cancer; TME; Left colonic artery;gastrointestinal function

由于直肠癌位置相对较低,因而在临床上容易被诊断出。但因其位置深入盆腔,且结构相对复杂,因此手术治疗难度较高,即使成功治疗后还是容易复发。临床上多采用经腹直肠癌根治术(TME)治疗,但关于肠系膜下动脉(IMA)处理还是存在不同意见。此次特针对我院130例患者分析,总结如下[1]。

1.1 一般资料

本次研究从时间范围在2020年3月至2021年3月中选择130例患者研究。所有患者均提前落实相关检查,并口服泻药做好肠道准备工作,诊断为直肠癌。纳入标准:①原发性肿瘤,并未接受辅助放疗或是其他治疗措施。②患者均具备治疗知情权,家属也了解此次研究目的。③术前評估,患者直肠癌分期为Ⅰ期、Ⅱ期、Ⅲ期。④无手术禁忌症。排除标准:①经诊断发现其肿瘤形态较大,已侵犯到周围器官。……

登录APP查看全文